Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 11441 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

How a mouse's brain bends time

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024
Related companies:  Cold Spring Harbor Laboratory (CSHL)

Zeigler Kalamazoo Marathon Announces Ascension Borgess as 2024 Foundational Sponsor

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024

NUTEX HEALTH ANNOUNCES YORKVILLE PAYOFF AND STREAMLINED STRATEGIC PLAN

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc. (EGRX) Investors of a Class Action Lawsuit and Upcoming Deadline

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024
Related companies:  Eagle Pharmaceuticals Inc.

Danaher Reports Fourth Quarter and Full Year 2023 Results

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024
Related companies:  Danaher Corporation

Excellent Dentistry Launches a New Website as it Celebrates 18 Years of Dental Care in Lake County

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024

GI Alliance and Ambience Healthcare Partner to Build Foundational AI Documentation Models for Gastroenterology

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024

Nanotechnology Products Market to Record Growth of USD 106.2 billion between 2022 to 2027, 3M Co., Advanced Nano Products Co. Ltd., Applied Materials Inc. to emerge as Some of the Key Vendors - Technavio

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024

Global Narcolepsy Drugs Market Forecast Reveals Surge to $6,138 Million by 2030 with Focus on Therapeutic Advancements

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024

SciBase initiates collaboration with Inderes for commissioned research

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024
Related companies:  SciBase Holding AB

Implantica's RefluxStop™ procedure now available in Norway

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024

Matisse Pharmaceuticals meets primary objectives in study with M6229 in critically ill sepsis patients

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024
Related companies:  Matisse Pharmaceuticals B.V.

Singleron launches the AccuraSCOPE® Single Cell Transcriptome

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024
Related companies:  Singleron Biotechnologies GmbH

Suanfarma unifies its industrial brands in a rebranding initiative under Suanfarma CDMO

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024

VENOMAID EXTENDS ITS SEED ROUND TO A TOTAL OF $ 1.8 M FOR AFFORDABLE AND RAPID SNAKEBITE DIAGNOSTICS

Read more ››
By: PR Newswire Association LLC. - 30 Jan 2024

Among the ongoing attacks on Ukraine, religious leaders aim to unite the Ukrainian religious diaspora and foster collaboration between Ukraine and the U.S. through Ukrainian Week 2024

Read more ››
By: GlobeNewswire - 30 Jan 2024

HUTCHMED Receives ELUNATE® (fruquintinib) Marketing Approval in Hong Kong for Treatment of Metastatic Colorectal Cancer

Read more ››
By: GlobeNewswire - 30 Jan 2024
Related companies:  HUTCHMED

BioSenic patent granted in Canada for broader protection of ATO therapeutic platform

Read more ››
By: GlobeNewswire - 30 Jan 2024
Related companies:  BioSenic SA

PolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoimmune therapy

Read more ››
By: GlobeNewswire - 30 Jan 2024
Related companies:  PolTREG S.A.

INTERIM REPORT FOR Q1 2023/24

Read more ››
By: GlobeNewswire - 30 Jan 2024
Related companies:  Ambu A/S
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑